Problems of Social Hygiene, Public Health and History of MedicineProblems of Social Hygiene, Public Health and History of Medicine0869-866X2412-2106Joint-Stock Company Chicot22910.32687/0869-866X-2019-27-6-1098-1101Научная статьяThe quality of life and accessibility of medical care in persons with bronchial asthma in the Republic of KazakhstanGazalievaM. A.-ZhumabekovaB. K.-KozhanovaR. T.-KasymbekovaB. K.-KoshkarbaevaB. S.-DedovaO. Iu.-IzmailovichM. R.-RahimzhanovaG. K.-AbdikalikovaD. R.-AndreevaO. B.andreyeva.olga@mail.ruGlushkovaN. E.-Karaganda Medical UniversitySemey Medical University151220192761098110106042021Copyright © 2019,2019The access barriers to asthma basic treatment and medical care in many countries are an urgent problem and emphasize the need for population studies to examine the associated risk factors for barriers to health care, causes of severe exacerbations, disruption of life quality, and the development of preventive measures. The purpose of study was to evaluate the association of quality of life, access to medical care and emergency of severe exacerbation in persons with bronchial asthma in the Republic of Kazakhstan. The cross-sectional study was applied. The sample included 3,572 patients of both genders aged 18-59 years with bronchial asthma, registered in out-patient clinics of the Republic of Kazakhstan. The assessment of frequency of severe exacerbation in patients with asthma, depending on availability of medical care, demonstrated significant differences in groups of minimal, average and maximum decrease (χ2 = 160.66, 2057.06, 166.19, p <0.001). The most of patients in group with severe asthma exacerbations more than 3 times per year had signs of a maximum decrease in access to medical care - 53.5% and 42.11% were classified as a medium-level barrier of access. The indicator of quality of life was significantly lower in group of patients with severe exacerbation of disease more than 3 times per year in groups with severe access barriers as compared to group with similar number of exacerbations where the number of barriers was less than two - 10.85 vs. 15, 28 (t = 3.985, D.f. = 1, p = 0.003). The study permitted to conclude that improving quality and increasing availability of medical care of asthmatic patient is the key to managing course of asthma at stage of diagnosis and during treatment as well.asthmaquality of lifeaccess to medical careAQLQGINAастмакачество жизнидоступность медицинской помощикачество жизни1.Braman S. S. The global burden of asthma. Chest. 2006;130(1):4-12.2.Bender B. G., Rand C. Medication non-adherence and asthma treatment cost. Curr. Opin. Allergy Clin. Immunol. 2004;(4):191-5.3.Mansour M. E., Lanphear B. P., DeWitt T. G. Barriers to asthma care in urban children: parent perspectives. Pediatrics. 2000;106(3): 512-9.4.Kim M., Asche C. V., Tillis W., Ren J. Association between availability of care providers and healthcare utilizations among adults with asthma. Curr. Med. Res. Opinion. 2017;33(3):479-87.5.Nurpeissov T., Nurpeissov T., Abdushukurova G., Nurpeissov T., Zhaksylykova A. Availability and compliance to basic therapy of bronchial asthma in rural region of Kazakhstan. Eur. Respir. J. 2013;42(57):3835.6.Nurpeissov T., Nurpeissov T., Abdushukurova G., Gazaliyeva M., Avdugalieva A., Shagiyeva A. Asthma spreading and primary diagnostics problems in rural regions of Kazakhstan. Clin. Translat. Allergy. 2015;5(2):22-3.7.Reddel H. K., Bateman E. D., Becker A., Boulet L.-P., Cruz A. A., Drazen J. M., Haahtela T., Hurd S. S., Inoue H., de Jongste J. C., Lemanske R. F., Levy M. L., O'Byrne P. M., Paggiaro P., Pedersen S. E., Pizzichini E., Soto-Quiroz M., Szefler S. J., Wong G. W., FitzGerald J. M. A summary of the new GINA strategy: a roadmap to asthma control. Eur. Respir. J. 2015;46(3):622-39.8.Reddel H. K., Taylor D. R., Bateman E. D., Boulet L.-P., Boushey H. A., Busse W. W., Casale T. B., Chanez P., Enright P. L., Gibson P. G., de Jongste J. C., Kerstjens H. A., Lazarus S. C., Levy M. L., O'Byrne P. M., Partridge M. R., Pavord I. D., Sears M. R., Sterk P. J., Stoloff S. W., Sullivan S. D., Szefler S. J., Thomas M. D., Wenzel S. E. An official American Thoracic Society. European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am. J. Respir. Crit. Care Med. 2009;180:59-99.9.Унгуряну Т. Н., Гржибовский А. М. Краткие рекомендации по описанию, статистическому анализу и представлению данных в научных публикациях. Экология человека. 2011;(5):55-60.10.Correia de Sousa J., Pina A., Cruz A. M., Quelhas A., Almada-Lobo F., Cabrita J., Oliveira P., Yaphe J. Asthma control, quality of life, and the role of patient enablement: a cross-sectional observational study. Prim. Care. Respir. J. 2013;22(2):181-7.11.Fleetcroft R., Noble M., Martin A., Coombes E., Ford J., Steel N. Emergency hospital admissions for asthma and access to primary care: cross-sectional analysis. Br. J. Gen. Pract. 2016;(1):1-7.